New Findings in Dementia and Alzheimer’s Research

According to the World Health Association, nearly 35 million people worldwide are living with Alzheimer’s disease. While this number continues to increase every year, so does the research around Alzheimer’s and other psychological conditions.

In a recent 2020 Alzheimer’s Association International Conference® (AAIC®), Dr. Maria Carrillo presented insights into the latest research and discoveries in her presentation titled Advancing the Science: The Latest Discoveries in Alzheimer’s Dementia Research. Here are some of the highlights of her findings:

Early Detection and Diagnosis

Biological markers can enable researchers to gauge bodily changes related to Alzheimer’s disease. Two main biomarkers for Alzheimer’s disease are Tau Tangles and Amyloid Plaques. A blood test can detect p-Tau217 – a tau tangle specific to the disease – 20 years before any symptoms of Alzheimer’s occur.

Biomarkers can help medical professionals with early detection and diagnosis. Consequently, it can help people concentrate on their health and slow the progression of the disease.

Lifestyle and Risk

While we cannot change certain risk factors like family history, age, and heredity, we can modify other factors like cardiovascular health, lifestyle, diet, physical activity, sleep, education, cognitive engagement, and brain injury.

The US POINTER study is a two-year clinical trial currently underway in Finland. It assesses whether interventions in lifestyle – like social and cognitive stimulation, physical activity, health coaching, and diet – can target risk factors of Alzheimer’s and protect seniors who are at risk for cognitive impairment.

Drug Trials

The biggest chunk of Alzheimer’s drugs in the pipeline in 2020 would try to slow down the process of loss of cognition and function. Anti-amyloid therapy that can treat MCI (Mild Cognitive Impairment) is in the process of seeking FDA’s approval. As a result of this treatment, researchers believe that there will be a decrease in clinical decline in tau-amyloid biomarkers and benefits on function and cognition.

Pneumonia and Flu Vaccination

The research conducted by AAIC suggested that pneumonia and flu vaccines are also correlated with a low risk of Alzheimer’s disease. Studies found out that a flu vaccine can decrease the prevalence of Alzheimer’s by 17%. Another study discovered that a pneumonia vaccine could decrease the risk of Alzheimer’s by 40% for senior citizens.

The ongoing research and latest findings make a strong case for behavioral interventions throughout a person’s life,  intending to reduce the risk and combat Alzheimer’s and other forms of dementia.

If you are concerned that your parents are developing certain symptoms, elder care services like senOcare can help you keep a close watch on them and get an early heads up if anything is wrong.

Call us today on +91 8800 003 046 or email us at [email protected].

senOcare provides comprehensive elder care services at home across multiple cities, including Delhi, Gurgaon, and Noida. You can choose from various care packages designed to support senior citizens, or they can also customize a package that caters to your specific requirements. senOcare can also arrange a tele-consult for your parents and you with a doctor, so that you can ask questions and make informed decisions. They offer a range of services related to health and fitness, home security and maintenance for elderly, technology help for elderly, forms and filing, and more.

We’ll be happy to help.